Table 2.
Extracranial dose in percentage of SRS prescription dose from literature and current series. Numbers in italics are from actual reported distances, numbers in plain text are interpolated from anatomical location to allow comparison between the data
| Craniocaudal distance from target (cm) | GKP (this study) | GKP (Lindquist) [18] | Novalis (Gevaert) [13] | Linac mMLC (Di Betta) [9] | Linac Cones (Di Betta) [9] | Cyberknife (Vlachopoulou) [29] | Cyberknife (Di Betta) [9] |
|---|---|---|---|---|---|---|---|
| Data from: | 20 patients | 1 humanoid phantom | 40 patients | 1 humanoid phantom | 1 humanoid phantom | 21 patients | 1 humanoid phantom |
| 15.5 | 0.9 | 1.26 | 0.418 | ||||
| 18.0 | 0.044 | 0.077 | 0.331 | 2.1 | |||
| 30.5 | 0.035 | 0.20 | 0.36 | 0.182 | |||
| 34.0 | 0.189 | 0.65 | |||||
| 43.0 | 0.010 | 0.013 | 0.092 | 0.174 | 0.154 | ||
| 53.0 | 0.0060 | 0.06 | 0.116 | 0.166 | |||
| 58.5 | 0.59 | ||||||
| 70.0 | 0.002 | 0.0027 | 0.025 | ||||
| 75.5 | 0.026 | 0.052 | 0.47 | 0.116 | |||
| 80.5 | 0.022 | 0.044 | 0.116 |